Sign up now to have the right to view
50 tenders for free.
Title |
Assay Validation Of High Quality Markers For Clinical Studies In Cancer (Uh3 Clinical Trials Not Allowed) Tender Notice International Competitive Bidding |
|||
---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
Country | ||||
Language | English | |||
Organization | ||||
Published Date | 16.10.2024 | |||
Deadline Date | 14.10.2026 | |||
Overview |
Assay Validation Of High Quality Markers For Clinical Studies In Cancer (Uh3 Clinical Trials Not Allowed) Through This Notice Of Funding Opportunity (Nofo), The National Cancer Institute (Nci) Intends To Accelerate The Adoption And Validation Of Molecular Cellular Imaging Markers (Referred To As "Markers" Or "Biomarkers") And Assays For Cancer Detection, Diagnosis, Prognosis, Monitoring, And Prediction Of Response Or Resistance To Treatment, As Well As Markers For Cancer Prevention And Control. This Nofo Will Also Support The Validation Of Pharmacodynamic Markers And Markers Of Toxicity. Applicants To This Nofo Must Have An Assay(S) Whose Performance Has Been Analytically Validated In Specimens Similar To Those For The Intended Clinical Use Of The Marker(S) And Assay(S). As Chemotherapies And Or Radiation Therapies Are Increasingly Combined With Immunotherapies To Enhance The Durability Of Anti-Cancer Responses, Assays For Measuring Multiple Markers, Including Immune Markers, Can Be Developed And Validated Simultaneously. The Uh3 Mechanism Will Support The Clinical Validation Of Established Assays For Up To 3 Years Using Specimens From Retrospective Or Prospective Clinical Trials Or Studies. This Nofo May Be Used To Validate Existing Assays For Use In Other Trials, Observational Studies, Or Population Studies. Efforts To Harmonize Clinical Laboratory Tests, Including Investigation Into The Performance And Reproducibility Of Assays Across Multiple Clinical Laboratories, Are Also Appropriate For This Funding Opportunity. Projects Proposed For This Nofo Will Require Multi-Disciplina... NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov Tender Notice International Competitive Bidding PAR-25-075 United States of America GT-108733560
|
|||
NAICS | ||||
CPVS |
Laboratory, optical and precision equipments (excl. glasses)
Control, safety, signalling and light equipment
Control, safety or signalling equipment for inland waterways
Document creation, drawing, imaging, scheduling and productivity software package
Control, safety or signalling equipment for parking facilities
Command, control, communication systems
Supports
Document creation, drawing, imaging, scheduling and productivity software development services
Control, safety or signalling equipment for port installations
Command, control, communication and computer systems
Markers
Laboratory, hygienic or pharmaceutical glassware
Pressure-reducing, control, check or safety valves
Control, safety or signalling equipment for roads
Control, safety or signalling equipment for airports
|
|||
UNSPSC | ||||
Regions | ||||
Sectors | ||||
URL | ||||
Share |
Title |
---|
Assay Validation Of High Quality Markers For Clinical Studies In Cancer (Uh3 Clinical Trials Not Allowed) Tender Notice International Competitive Bidding |
Country |
Language |
English |
Organization |
Published Date |
16.10.2024 |
Deadline Date |
14.10.2026 |
Overview |
Assay Validation Of High Quality Markers For Clinical Studies In Cancer (Uh3 Clinical Trials Not Allowed) Through This Notice Of Funding Opportunity (Nofo), The National Cancer Institute (Nci) Intends To Accelerate The Adoption And Validation Of Molecular Cellular Imaging Markers (Referred To As "Markers" Or "Biomarkers") And Assays For Cancer Detection, Diagnosis, Prognosis, Monitoring, And Prediction Of Response Or Resistance To Treatment, As Well As Markers For Cancer Prevention And Control. This Nofo Will Also Support The Validation Of Pharmacodynamic Markers And Markers Of Toxicity. Applicants To This Nofo Must Have An Assay(S) Whose Performance Has Been Analytically Validated In Specimens Similar To Those For The Intended Clinical Use Of The Marker(S) And Assay(S). As Chemotherapies And Or Radiation Therapies Are Increasingly Combined With Immunotherapies To Enhance The Durability Of Anti-Cancer Responses, Assays For Measuring Multiple Markers, Including Immune Markers, Can Be Developed And Validated Simultaneously. The Uh3 Mechanism Will Support The Clinical Validation Of Established Assays For Up To 3 Years Using Specimens From Retrospective Or Prospective Clinical Trials Or Studies. This Nofo May Be Used To Validate Existing Assays For Use In Other Trials, Observational Studies, Or Population Studies. Efforts To Harmonize Clinical Laboratory Tests, Including Investigation Into The Performance And Reproducibility Of Assays Across Multiple Clinical Laboratories, Are Also Appropriate For This Funding Opportunity. Projects Proposed For This Nofo Will Require Multi-Disciplina... NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov Tender Notice International Competitive Bidding PAR-25-075 United States of America GT-108733560 |
NAICS |
Navigational Other Direct Insurance (except Life Electric Power Transmission Direct Insurance (except Life Investigation Direct Life International Measuring Search Navigational |
CPVS |
Laboratory, optical and precision equipments (excl. glasses) Control, safety, signalling and light equipment Control, safety or signalling equipment for inland waterways Document creation, drawing, imaging, scheduling and productivity software package Control, safety or signalling equipment for parking facilities Command, control, communication systems Supports Document creation, drawing, imaging, scheduling and productivity software development services Control, safety or signalling equipment for port installations Command, control, communication and computer systems Markers Laboratory, hygienic or pharmaceutical glassware Pressure-reducing, control, check or safety valves Control, safety or signalling equipment for roads Control, safety or signalling equipment for airports |
UNSPSC |
Markers Population Airport Maps, Networks (GIS), Studies |
Regions |
APEC Countries North America Northern America |
Sectors |
Automobiles and Auto Parts Non-Renewable Energy Postal and Courier Services Oil and Gas Printing and Publishing Defence and Security Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Laboratory Equipment and Services Marine |
URL |
Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Tenders